Now, we demonstrate for the first time that IL-24 inhibits eIF4A expression in prostate cancer cells (DU-145), melanoma (HO-1), breast cancer cells (MCF-7), and cervical cancer cells (HeLa) (Figure 1A). This evidence concerns the gene IL24 and cervical carcinoma.